Skip to content

Clinical trials

Terminated Lymphoproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Status: Terminated Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20043
20053
20061
20074
20081
20092
20104
20112
20121
20152
20181
20193
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center2
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
miRagen Therapeutics, Inc.2
AO GENERIUM1
Alliance for Clinical Trials in Oncology1
Ariad Pharmaceuticals1
Barbara Ann Karmanos Cancer Institute1
Baylor College of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders33
Lymphoma17
Lymphoma, Non-Hodgkin14
Immune System Diseases11
Leukemia11
Lymphatic Diseases10
Lymphoma, Large B-Cell, Diffuse10
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Immunoproliferative Disorders8
Lymphoma, T-Cell, Cutaneous8

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.